Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis

Neurobiology of Disease

Volumn 82, Issue , 2015, Pages 526-539

  Amhaoul, Halima ^a   Hamaide, Julie ^a   Bertoglio, Daniele ^a   Reichel, Stephanie Nadine ^a   Verhaeghe, Jeroen ^a   Geerts, Elly ^a   Van Dam, Debby ^a   De Deyn, Peter Paul ^a,b,c   Kumar Singh, Samir ^a   Katsifis, Andrew ^d   Van Der Linden, Annemie ^a   Staelens, Steven ^a   Dedeurwaerdere, Stefanie ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Memory Clinic   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

18F PBR111 PET; Brain and neuroinflammation; Epilepsy; Microglia; Seizure; Translocator protein or peripheral benzodiazepine receptor

Indexed keywords

BIOLOGICAL MARKER; FLUORINE 18; KAINIC ACID; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID A RECEPTOR; CARRIER PROTEIN; TSPO PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ATROPHY; BRAIN REGION; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENCEPHALITIS; EPILEPTIC STATE; EPILEPTOGENESIS; FOLLOW UP; IN VITRO STUDY; IN VIVO STUDY; LONGITUDINAL STUDY; MALE; MICROGLIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE TRANSITION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; STUDY DESIGN; UPREGULATION; VOLUMETRY; WISTAR HANNOVER RAT; ANIMAL; AUTORADIOGRAPHY; BRAIN; CHRONIC DISEASE; DISEASE COURSE; DISEASE MODEL; ELECTROCORTICOGRAPHY; EPILEPSY; GLIA; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; SCINTISCANNING; WISTAR RAT;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CARRIER PROTEINS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROCORTICOGRAPHY; ENCEPHALITIS; EPILEPSY; FOLLOW-UP STUDIES; IMMUNOHISTOCHEMISTRY; KAINIC ACID; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NERVE DEGENERATION; NEUROGLIA; NEURONS; POSITRON-EMISSION TOMOGRAPHY; RATS, WISTAR; RECEPTORS, GABA-A;

EID: 84947020504     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.09.004     Document Type: Article

References (60)

1. Altar C.A., Baudry M. Systemic injection of kainic acid: gliosis in olfactory and limbic brain regions quantified with [3H]PK 11195 binding autoradiography. Exp. Neurol. 1990, 109:333-341.
2. Amhaoul H., Staelens S., Dedeurwaerdere S. Imaging brain inflammation in epilepsy. Neuroscience 2014, 279C:238-252.
3. Arlicot N., Tronel C., Bodard S., Garreau L., de la Crompe B., Vandevelde I., Guilloteau D., Antier D., Chalon S. Translocator protein (18kDa) mapping with [125I]-CLINDE in the quinolinic acid rat model of excitotoxicity: a longitudinal comparison with microglial activation, astrogliosis, and neuronal death. Mol. Imaging 2014, 13:4-11.
4. Banati R.B., Goerres G.W., Myers R., Gunn R.N., Turkheimer F.E., Kreutzberg G.W., Brooks D.J., Jones T., Duncan J.S. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999, 53:2199-2203.
5. Biagini G., Baldelli E., Longo D., Pradelli L., Zini I., Rogawski M.A., Avoli M. Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp. Neurol. 2006, 201:519-524.
6. Boer K., Spliet W.G., van Rijen P.C., Redeker S., Troost D., Aronica E. Evidence of activated microglia in focal cortical dysplasia. J. Neuroimmunol. 2006, 173:188-195.
7. Bogdanovic R.M., Syvanen S., Michler C., Russmann V., Eriksson J., Windhorst A.D., Lammertsma A.A., de Lange E.C., Voskuyl R.A., Potschka H. (R)-[C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model. Neuropharmacology 2014, 85C:104-112.
8. Butler T., Ichise M., Teich A.F., Gerard E., Osborne J., French J., Devinsky O., Kuzniecky R., Gilliam F., Pervez F., Provenzano F., Goldsmith S., Vallabhajosula S., Stern E., Silbersweig D. Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J. Neuroimaging 2013, 23:129-131.
9. Chen C., Lang S., Xu G., Liu X., Zuo P. Effects of topiramate on seizure susceptibility in kainate-kindled rats: involvement of peripheral-type benzodiazepine receptors. Seizure 2008, 17:358-363.
10. Cosenza-Nashat M., Zhao M.L., Suh H.S., Morgan J., Natividad R., Morgello S., Lee S.C. Expression of the translocator protein of 18kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol. Appl. Neurobiol. 2009, 35:306-328.
11. Dedeurwaerdere S., Callaghan P.D., Pham T., Rahardjo G.L., Amhaoul H., Berghofer P., Quinlivan M., Mattner F., Loc'h C., Katsifis A., Gregoire M.C. PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. EJNMMI Res. 2012, 2:60.
12. Dedeurwaerdere S., Fang K., Chow M., Shen Y.T., Noordman I., van Raay L., Faggian N., Porritt M., Egan G.F., O'Brien T.J. Manganese-enhanced MRI reflects seizure outcome in a model for mesial temporal lobe epilepsy. NeuroImage 2013, 68:30-38.
13. Dedeurwaerdere S., Friedman A., Fabene P.F., Mazarati A., Murashima Y.L., Vezzani A., Baram T.Z. Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia 2012, 53:1113-1118.
14. Dedeurwaerdere S., van Raay L., Morris M.J., Reed R.C., Hogan R.E., O'Brien T.J. Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy. Seizure 2011, 20:72-79.
15. Defrise M., Kinahan P.E., Townsend D.W., Michel C., Sibomana M., Newport D.F. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans. Med. Imaging 1997, 16:145-158.
16. Dickens A.M., Vainio S., Marjamaki P., Johansson J., Lehtiniemi P., Rokka J., Rinne J., Solin O., Haaparanta-Solin M., Jones P.A., Trigg W., Anthony D.C., Airas L. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J. Nucl. Med. 2014, 55:466-472.
17. Drexel M., Preidt A.P., Sperk G. Sequel of spontaneous seizures after kainic acid-induced status epilepticus and associated neuropathological changes in the subiculum and entorhinal cortex. Neuropharmacology 2012, 63:806-817.
18. Dube C., Vezzani A., Behrens M., Bartfai T., Baram T.Z. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol. 2005, 57:152-155.
19. Ebert U., Wlaz P., Loscher W. High susceptibility of the anterior and posterior piriform cortex to induction of convulsions by bicuculline. Eur. J. Neurosci. 2000, 12:4195-4205.
20. Friedman A., Kaufer D., Heinemann U. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res. 2009, 85:142-149.
21. Galic M.A., Riazi K., Pittman Q.J. Cytokines and brain excitability. Front. Neuroendocrinol. 2012, 33:116-125.
22. Gershen L.D., Zanotti-Fregonara P., Dustin I.H., Liow J.S., Hirvonen J., Kreisl W.C., Jenko K.J., Inati S.K., Fujita M., Morse C.L., Brouwer C., Hong J.S., Pike V.W., Zoghbi S.S., Innis R.B., Theodore W.H. Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein. JAMA Neurol. 2015, 72:882-888.
23. Goerres G.W., Revesz T., Duncan J., Banati R.B. Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK11195 positron emission tomography. AJR Am. J. Roentgenol. 2001, 176:1016-1018.
24. Guilarte T.R., Kuhlmann A.C., O'Callaghan J.P., Miceli R.C. Enhanced expression of peripheral benzodiazepine receptors in trimethyltin-exposed rat brain: a biomarker of neurotoxicity. Neurotoxicology 1995, 16:441-450.
25. Hattiangady B., Rao M.S., Shetty A.K. Chronic temporal lobe epilepsy is associated with severely declined dentate neurogenesis in the adult hippocampus. Neurobiol. Dis. 2004, 17:473-490.
26. Hirvonen J., Kreisl W.C., Fujita M., Dustin I., Khan O., Appel S., Zhang Y., Morse C., Pike V.W., Innis R.B., Theodore W.H. Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J. Nucl. Med. 2012, 53:234-240.
27. Hu S., Sheng W.S., Ehrlich L.C., Peterson P.K., Chao C.C. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 2000, 7:153-159.
28. Hudson H.M., Larkin R.S. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans. Med. Imaging 1994, 13:601-609.
29. Ji B., Maeda J., Sawada M., Ono M., Okauchi T., Inaji M., Zhang M.R., Suzuki K., Ando K., Staufenbiel M., Trojanowski J.Q., Lee V.M., Higuchi M., Suhara T. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J. Neurosci. 2008, 28:12255-12267.
30. Johnson E.W., de Lanerolle N.C., Kim J.H., Sundaresan S., Spencer D.D., Mattson R.H., Zoghbi S.S., Baldwin R.M., Hoffer P.B., Seibyl J.P., et al. "Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 1992, 42:811-815.
31. Katsifis A., Loc'h C., Henderson D., Bourdier T., Pham T., Greguric I., Lam P., Callaghan P., Mattner F., Eberl S., Fulham M. A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [(18)F]PBR102 and [(18)F]PBR111, in rat and primate plasma. Nucl. Med. Biol. 2011, 38:137-148.
32. Kelly M.E., McIntyre D.C. Perirhinal cortex involvement in limbic kindled seizures. Epilepsy Res. 1996, 26:233-243.
33. Kumar A., Chugani H.T., Luat A., Asano E., Sood S. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr. Neurol. 2008, 38:439-442.
34. Kumlien E., Hilton-Brown P., Spannare B., Gillberg P.G. In vitro quantitative autoradiography of [3H]-L-deprenyl and [3H]-PK 11195 binding sites in human epileptic hippocampus. Epilepsia 1992, 33:610-617.
35. Lavisse S., Guillermier M., Herard A.S., Petit F., Delahaye M., Van Camp N., Ben Haim L., Lebon V., Remy P., Dolle F., Delzescaux T., Bonvento G., Hantraye P., Escartin C. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J. Neurosci. 2012, 32:10809-10818.
36. Le Fur G., Guilloux F., Rufat P., Benavides J., Uzan A., Renault C., Dubroeucq M.C., Gueremy C. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci. 1983, 32:1849-1856.
37. Maia S., Arlicot N., Vierron E., Bodard S., Vergote J., Guilloteau D., Chalon S. Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease. Synapse 2012, 66:573-583.
38. Martin A., Boisgard R., Theze B., Van Camp N., Kuhnast B., Damont A., Kassiou M., Dolle F., Tavitian B. Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2010, 30:230-241.
39. Missault S., Van den Eynde K., Vanden Berghe W., Fransen E., Weeren A., Timmermans J.P., Kumar-Singh S., Dedeurwaerdere S. The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain Behav. Immun. 2014, 42:138-146.
40. Ngugi A.K., Bottomley C., Kleinschmidt I., Sander J.W., Newton C.R. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010, 51:883-890.
41. Noda M., Suzumura A. Sweepers in the CNS: microglial migration and phagocytosis in the Alzheimer disease pathogenesis. Int. J. Alzheimers Dis. 2012, 2012:891087.
42. Patel A.R., Ritzel R., McCullough L.D., Liu F. Microglia and ischemic stroke: a double-edged sword. Int. J. Physiol. Pathophysiol. Pharmacol. 2013, 5:73-90.
43. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Elsevier Inc.
44. Pike V.W., Halldin C., Crouzel C., Barre L., Nutt D.J., Osman S., Shah F., Turton D.R., Waters S.L. Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites-current status. Nucl. Med. Biol. 1993, 20:503-525.
45. Pitkanen A., Nissinen J., Nairismagi J., Lukasiuk K., Grohn O.H., Miettinen R., Kauppinen R. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog. Brain Res. 2002, 135:67-83.
46. van Raay L., Morris M.J., Reed R.C., O'Brien T.J., Dedeurwaerdere S. A novel system allowing long-term simultaneous video-electroencephalography recording, drug infusion and blood sampling in rats. J. Neurosci. Methods 2009, 179:184-190.
47. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
48. Ravizza T., Balosso S., Vezzani A. Inflammation and prevention of epileptogenesis. Neurosci. Lett. 2011, 497:223-230.
49. Ravizza T., Boer K., Redeker S., Spliet W.G., van Rijen P.C., Troost D., Vezzani A., Aronica E. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol. Dis. 2006, 24:128-143.
50. Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
51. Saijo K., Glass C.K. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 2011, 11:775-787.
52. Sauvageau A., Desjardins P., Lozeva V., Rose C., Hazell A.S., Bouthillier A., Butterwort R.F. Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis. Metab. Brain Dis. 2002, 17:3-11.
53. Sharma A.K., Jordan W.H., Reams R.Y., Hall D.G., Snyder P.W. Temporal profile of clinical signs and histopathologic changes in an F-344 rat model of kainic acid-induced mesial temporal lobe epilepsy. Toxicol. Pathol. 2008, 36:932-943.
54. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 2005, 25:3219-3228.
55. Van den Eynde K., Missault S., Fransen E., Raeymaekers L., Willems R., Drinkenburg W., Timmermans J.P., Kumar-Singh S., Dedeurwaerdere S. Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia. Behav. Brain Res. 2014, 258:179-186.
56. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
57. White A., Williams P.A., Hellier J.L., Clark S., Dudek F.E., Staley K.J. EEG spike activity precedes epilepsy after kainate-induced status epilepticus. Epilepsia 2010, 51:371-383.
58. Williams P.A., White A.M., Clark S., Ferraro D.J., Swiercz W., Staley K.J., Dudek F.E. Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J. Neurosci. 2009, 29:2103-2112.
59. Wittner L., Eross L., Czirjak S., Halasz P., Freund T.F., Magloczky Z. Surviving CA1 pyramidal cells receive intact perisomatic inhibitory input in the human epileptic hippocampus. Brain 2005, 128:138-152.
60. Zattoni M., Mura M.L., Deprez F., Schwendener R.A., Engelhardt B., Frei K., Fritschy J.M. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J. Neurosci. 2011, 31:4037-4050.